This study explored the prognostic significance of immunohistochemical loss of T-cell antigens—specifically CD2, CD3, CD5, and CD7—in patients diagnosed with early-stage mycosis fungoides (MF). This evidence concerns the gene CD5 and mycosis fungoides.